Journal
PIGMENT CELL & MELANOMA RESEARCH
Volume 26, Issue 4, Pages -Publisher
WILEY
DOI: 10.1111/pcmr.12110
Keywords
AXL; MERTK; melanoma; migration; survival
Categories
Funding
- Yale SPORE in Skin Cancer [P50 CA121974]
- Harry J Lloyd Charitable Trust
- National Science Foundation Graduate Research Fellowship
Ask authors/readers for more resources
The receptor tyrosine kinase AXL regulates melanoma cell proliferation and migration. We now demonstrate that AXL and the related kinase MERTK are alternately expressed in melanoma and are associated with different transcriptional signatures. MERTK-positive melanoma cells are more proliferative and less migratory than AXL-positive melanoma cells and overexpression of AXL increases cell motility relative to MERTK. MERTK is expressed in up to 50% of melanoma cells and shRNA-mediated knockdown of MERTK reduces colony formation and cell migration in a CDC42-dependent fashion. Targeting MERTK also decreases cell survival and proliferation in an AKT-dependent manner. Finally, we identify a novel mutation in the kinase domain of MERTK, MERTKP802S, that increases the motility of melanoma cells relative to wild-type MERTK. Together, these data demonstrate that MERTK is a possible therapeutic target in melanoma, that AXL and MERTK are associated with differential cell behaviors, and that mutations in MERTK may contribute to melanoma pathogenesis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available